These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 34234853)
1. Shikonin Inhibits Tumor Growth of ESCC by suppressing PKM2 mediated Aerobic Glycolysis and STAT3 Phosphorylation. Zhang Q; Liu Q; Zheng S; Liu T; Yang L; Han X; Lu X J Cancer; 2021; 12(16):4830-4840. PubMed ID: 34234853 [No Abstract] [Full Text] [Related]
2. Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway. Zhang J; Zhou J; Xiao S Anticancer Drugs; 2020 Oct; 31(9):932-941. PubMed ID: 32282369 [TBL] [Abstract][Full Text] [Related]
3. Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis. Zhao X; Zhu Y; Hu J; Jiang L; Li L; Jia S; Zen K Sci Rep; 2018 Sep; 8(1):14517. PubMed ID: 30266938 [TBL] [Abstract][Full Text] [Related]
4. Pterostilbene suppresses the growth of esophageal squamous cell carcinoma by inhibiting glycolysis and PKM2/STAT3/c-MYC signaling pathway. Yang Y; Li S; Shi W; Jin G; Guo D; Li A; Wang B; Lu B; Feng S Int Immunopharmacol; 2024 Dec; 142(Pt B):113247. PubMed ID: 39321706 [TBL] [Abstract][Full Text] [Related]
5. Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway. Dai Y; Liu Y; Li J; Jin M; Yang H; Huang G Bioengineered; 2022 May; 13(5):13906-13918. PubMed ID: 35706397 [TBL] [Abstract][Full Text] [Related]
6. Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2. Liu T; Li S; Wu L; Yu Q; Li J; Feng J; Zhang J; Chen J; Zhou Y; Ji J; Chen K; Mao Y; Wang F; Dai W; Fan X; Wu J; Guo C J Hepatocell Carcinoma; 2020; 7():19-31. PubMed ID: 32110554 [TBL] [Abstract][Full Text] [Related]
7. Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line. Yang W; Liu J; Hou L; Chen Q; Liu Y Life Sci; 2021 Jan; 265():118796. PubMed ID: 33220292 [TBL] [Abstract][Full Text] [Related]
8. Shikonin ameliorated mice colitis by inhibiting dimerization and tetramerization of PKM2 in macrophages. Huang B; Wang Q; Jiang L; Lu S; Li C; Xu C; Wang C; Zhang E; Zhang X Front Pharmacol; 2022; 13():926945. PubMed ID: 36059938 [TBL] [Abstract][Full Text] [Related]
9. Signal transducer and activator of transcription 3 promotes the Warburg effect possibly by inducing pyruvate kinase M2 phosphorylation in liver precancerous lesions. Bi YH; Han WQ; Li RF; Wang YJ; Du ZS; Wang XJ; Jiang Y World J Gastroenterol; 2019 Apr; 25(16):1936-1949. PubMed ID: 31086462 [TBL] [Abstract][Full Text] [Related]
10. Platelet-rich plasma improves chronic inflammatory pain by inhibiting PKM2-mediated aerobic glycolysis in astrocytes. Wei X; Jin XH; Meng XW; Hua J; Ji FH; Wang LN; Yang JP Ann Transl Med; 2020 Nov; 8(21):1456. PubMed ID: 33313201 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2. Zhang K; Zhang M; Jiang H; Liu F; Liu H; Li Y Biomed Pharmacother; 2018 Sep; 105():545-552. PubMed ID: 29886375 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Shikonin against Esophageal Cancer Cells and its possible mechanisms Tang JC; Zhao J; Long F; Chen JY; Mu B; Jiang Z; Ren Y; Yang J J Cancer; 2018; 9(1):32-40. PubMed ID: 29290767 [TBL] [Abstract][Full Text] [Related]
14. [Shikonin induces hepatocellular carcinoma cell apoptosis by suppressing PKM2/PHD3/HIF-1 Zhang H; Chen Z; Zhao X; Huo Q; Cheng X Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jan; 43(1):92-98. PubMed ID: 36856215 [TBL] [Abstract][Full Text] [Related]
15. Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis. Gao P; Shen S; Li X; Liu D; Meng Y; Liu Y; Zhu Y; Zhang J; Luo P; Gu L Drug Des Devel Ther; 2020; 14():2091-2100. PubMed ID: 32546972 [TBL] [Abstract][Full Text] [Related]
16. miR-133b Promotes Esophageal Squamous Cell Carcinoma Metastasis. Huang CG; Liu Q; Zheng ST; Liu T; Tan YY; Peng TY; Chen J; Lu XM Clin Med Insights Oncol; 2023; 17():11795549231219502. PubMed ID: 38144543 [TBL] [Abstract][Full Text] [Related]
17. Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma. de Andrade Barreto E; de Souza Santos PT; Bergmann A; de Oliveira IM; Wernersbach Pinto L; Blanco T; Rossini A; Pinto Kruel CD; Mattos Albano R; Ribeiro Pinto LF Exp Mol Pathol; 2016 Aug; 101(1):66-73. PubMed ID: 27260309 [TBL] [Abstract][Full Text] [Related]
18. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells. Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881 [TBL] [Abstract][Full Text] [Related]
19. WZB117 enhanced the anti-tumor effect of apatinib against melanoma via blocking STAT3/PKM2 axis. Zhang RS; Li ZK; Liu J; Deng YT; Jiang Y Front Pharmacol; 2022; 13():976117. PubMed ID: 36188586 [No Abstract] [Full Text] [Related]
20. PKM2 inhibitor shikonin suppresses TPA-induced mitochondrial malfunction and proliferation of skin epidermal JB6 cells. Li W; Liu J; Zhao Y Mol Carcinog; 2014 May; 53(5):403-12. PubMed ID: 23255458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]